Friday, 19 September 2014

Global Antibiotics Industry Insights and 2018 Forecast Report

Global Antibiotics Market 2014-2018 is the latest addition to industry research reports collection. 

Antibacterial drugs are chemical compounds used to kill or inhibit the growth of bacteria. The term “antibiotic” is often used synonymously with antibacterial; however, the term “antibiotic” was originally coined to refer to the antibacterial compounds of microbial origin. Antibacterial acts via various mechanisms such as the inhibition of cell wall synthesis, the inhibition of nucleic acid synthesis, the disruption of the cell membrane, and the inhibition of protein synthesis. It can be bacteriostatic or bactericidal in nature. Antibiotics are medicines that are used to treat infections caused by bacteria (e.g., respiratory tract infections). Antibiotics work against microorganisms such as bacteria, fungi, and parasites but are not effective against viruses. Antibiotics either block vital processes in bacteria, kill the bacteria, or halt them from growing. Antibiotics that affect a wide range of bacteria are called broad spectrum antibiotics (e.g., amoxicillin and gentamicin). Antibiotics that affect only a few types of bacteria are called narrow spectrum antibiotics (e.g., penicillin).
Analysts forecast the Global Antibiotics market to grow at a CAGR of 1.41 percent over the period 2013-2018.
The report recognizes the following companies as the key players in the Global Antibiotics Market: AstraZeneca plc, Eli Lilly & Co., GlaxoSmithKline plc, Johnson & Johnson Ltd., Novartis AG, Pfizer Inc. and Sanofi.

Other Prominent Vendors in the market are: Bayer HealthCare, Bristol-Myers Squibb, Cubist Pharmaceuticals, Daiichi Sankyo, F. Hoffmann-La Roche and Takeda Pharmaceutical.
One key trend emerging in this market is the increase in demand for antibiotics, which is attracting various companies to the pharmaceutical space. The increase in demand for antibiotics to counter growing cases of drug-resistant infections offers ideal opportunities for pharmaceutical companies to introduce new products into the marketplace.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Antibiotics market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various antibiotics for human use. The Global Antibiotics market can be divided into eight segments: Beta-lactams, Macrolides, Aminoglycosides, Phenicols, Quinolones, Sulfonamides, Tetracyclines, and Others.

Global Antibiotics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Antibiotics market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

According to the report, one of the main drivers in this market is the increasing global aging population. The elderly are more likely to acquire infections and require hospitalization. The elderly are more prone to hospital-acquired infections. Therefore, more treatment options, including antibiotics, are needed to meet the treatment requirements of the growing elderly population.

Further, the report states that one of the main challenges that this market confronts is the emergence of drug-resistant strains. These drug-resistant infectious agents can easily spread to other regions as they are able to persist inside the human body despite treatment with standard therapies.

Single User License of the Report is Available at USD 2500, Buy the Report @ .